Rapid detection of scrub typhus using infexn®-NGS test

infexn®-NGS test accurately detects Orientia tsutsugamushi from blood samples of the patient.

infexn®-NGS accurately detects murine typhus in a 75-year-old recently returned traveller

infexn®-NGS test accurately detects Rickettsia typhi from blood samples of a 75-year-old returned traveller suffering from fever of unknown origin.

Current day challenges in infectious disease diagnostics

Explore the solutions to current infectious disease diagnostic challenges.

Sepsis Treatment with Genomics

The window for sepsis intervention is small, but genomics is opening new doors for faster, precise treatment. We’re closer than ever to stopping sepsis before it’s too late.

Unmasking the pathogens: A meta-genomic approach to infectious diseases

Watch Dr Aneesh, Principal Scientist & Head - Center of Genomic Medicine, NIMS Medicity Hospital, Trivandrum, an early user of infexn®, talk about the following in this webinar.

Clinical Grade NGS at Max Saket - A Leap in ID Diagnosis

Listen to how infexn®-NGS is helping clinicians overcome the diagnostic challenges associated with infectious diseases.

OXFORD NANOPORE GULF SUMMIT 2024 - DUBAI

Dr. Anirvan shared valuable learnings on pathogen research across ICUs at the Oxford Nanopore Gulf Summit 2024 - Dubai.

FICCI HEALTHCARE EXCELLENCE AWARDS 2024

HaystackAnalytics is honored to receive the FICCI Healthcare Excellence Award for Digital Transformation Initiative of the Year. We extend our gratitude to the esteemed panel for this recognition, which reinforces our commitment to driving innovation and excellence in the HealthTech industry.

FE Healthcare Awards

Thrilled and honored to receive not one, but two prestigious awards at the FE Healthcare Awards! Winning the Silver Award in Health Tech Startup of the Year and the Gold Award for Health Tech Solution of the Year is a testament to our team's hard work and dedication. Thank you for the recognition!

ECCMID Global Conference, Barcelona

Dr. Mahua Dasgupta presented an engaging clinical case session on Next-Generation Sequencing of non-culturable pathogens, Orientia tsutsugamushi, at the esteemed ECCMID conference.

GICS Bengaluru

The GICS 2024 event in Bengaluru was a truly insightful gathering of industry leaders and medical experts. We showcased infexn®-NGS, our groundbreaking product, to leading doctors and healthcare professionals. The event covered insightful interactions, innovative demos, and a shared vision for a future where precision diagnostics leads the way.

IMACON

HaystackAnalytics proudly participated in the 43rd IMA Annual Convention, where our sales team showcased infexn® NGS along with our portfolio of advanced sequencing-based diagnostic solutions. The team engaged with healthcare professionals, highlighting how our cutting-edge technologies are transforming infectious disease diagnostics through precision and speed.

TAPICON

HaystackAnalytics participated in the 14th TAPICON event organized by Thane Academy of Pediatrics at Thorale Bajirao Peshwe Sabhagruha, Thane on December 08, 2024. Dr. Mahua Dasgupta discussed the relevance and utility of infexn-NGS test in the diagnosis of pediatric sepsis supported by real-world data evidence.

MALCON

HaystackAnalytics participated in MALCON 2025, showcasing the clinical relevance of infexn® — a comprehensive sequencing-based diagnostic solution for infectious diseases. The session highlighted how infexn® NGS enables accurate and timely identification of pathogens across a wide range of infections, paving the way for improved clinical decision-making and patient outcomes.

MEDCON 2025

At MedCon 2025, HaystackAnalytics spotlighted infexn®—a powerful sequencing-based diagnostic solution for infectious diseases. With its ability to rapidly and accurately identify a broad range of pathogens, infexn® NGS equips clinicians with critical insights for effective diagnosis and treatment.

Maharashtra Association of Physicians, Mumbai 2025

At the Maharashtra Association of Physicians event held in Mumbai, Dr. Siddhant Shetty presented Targeted NGS for Managing Infections: A Case Study-Based Approach. The session highlighted how infexn® NGS is transforming infection diagnostics through advanced sequencing technology and real-world clinical impact.

STARTUP MAHAKUMBH

HaystackAnalytics marked its presence at the Startup Mahakumbh event, showcasing innovative solutions in the healthcare and diagnostic sector. The event provided a platform to engage with industry leaders, entrepreneurs, and investors, highlighting our cutting-edge technologies, including infexn® NGS. We shared insights on how our advancements in pathogen detection and genetic diagnostics are shaping the future of healthcare and precision medicine.

Annual Conference of Jagjivan Ram Hospital

HaystackAnalytics marked its presence at JRHCON 2025, the Annual Conference of Jagjivan Ram Hospital. Our sales team showcased iinfexn® NGS, an advanced sequencing-based solution designed for comprehensive pathogen detection, sparking meaningful conversations around the future of infectious disease diagnostics.

01-02-2025

How is NGS changing the paradigm of infectious disease diagnosis?

Decisions on the choice of the right empiric therapy have been challenging owing to the growing burden of antibiotic resistance and the inherent limitations of current-day diagnostics.